7A: Advanced Applications and Novel Methods in 3D Bioprinting 2

Date: Saturday, April 12, 2025
Time: 8:00 AM to 10:00 AM
Room: Grand Ballroom
Session Type: General Session

Description

3D bioprinting has emerged as a leading biofabrication technique to both engineer tissues for regenerative medicine and create microphysiological models for drug screening and personalized medicine. This symposium will focus on advances in 3D bioprinting methods ranging from hardware design, AI-based software, multifunctional biomaterials, and novel bioink formulations. Specific attention will be given to open-source technological advances driving the rapid innovation and widespread adoption, as well as current challenges and future strategies towards commercialization of bioprinted medical devices. We will additionally highlight new developments from industry, 4D bioprinting, and cover examples of in vivo bioprinting. Our goal is to assimilate novel methods in mechanical design, software analysis, materials development, and medical device construction to encourage the next wave of 3D printing innovation.

Moderators:

Daniel Shiwarski, University of Pittsburgh

Objectives

  • 11:00 AM. 312. TissueFab® Synthetic DLP bioink for Advanced Tissue and Organ-on-a-Chip Applications.CANCAN XU1, Ganga Panambur1, Elizabeth Aisenbrey1, Adam Raw1 1MilliporeSigma

  • 11:15 AM. 313. Digital Light Processing 3D Bioprinting of Biomimetic Corneal Stroma Equivalent using Gelatin Methacryloyl and Oxidized Carboxymethylcellulose Interpenetrating Network Hydrogel.Gopinathan Janarthanan1, Kamil Elkhoury2, Sanjairaj Vijayavenkataraman3, Rashik Chand4 1New York University Abu Dhab, 2New York University Abu Dhabi,, 3Tandon School of Engineering, New York University & New York University Abu Dhabi, 4New York University Abu Dhabi & Tandon School of Engineering, New York University

  • 11:30 AM. 314. Synergistic Effects of Periostin and Oxygen Generators in Complex Skin Tissue 4D Bioprinting.Maedeh Rahimnejad1, Jinping Xu1, Cristiane Squarize1, Rogerio Castilho1, Marco Bottino1 1University of Michigan

  • 11:45 AM. 315. 3D Printing Bioresorbable Scaffolds for Wound Healing via Engineering Stochastic Voronoi Structures.Mohsen Esmaeili, PhD1, Alex Wong1, Michael Vaughn, Ph.D.1 1Poly-Med, Inc.

  • 12:00 PM. 316. Magnetic Mixer (MagMix): Advancing Bioink Homogeneity in Extrusion-Based Bioprinting.Ferdows Afghah1, Ava Ladd1, Verra McCoy1, Farrah Ye1, Jane Bai1, Ritu Raman1 1MIT

  • 12:15 PM. 317. Automated Organoid and Cell Spheroid Assembly for Enhanced Disease Modeling.Remington Martinez, BSE1, Taylor Bertucci, PhD2, Christopher Highley, PhD1 1University of Virginia, 2Neural Stem Cell Institute

Speakers

7B: Biomaterials for Cancer Immunotherapy

Date: Saturday, April 12, 2025
Time: 8:00 AM to 10:00 AM
Room: BLVD B
Session Type: General Session

Description

The past decade has witnessed the roaring development of immunotherapies for clinical cancer treatment. Immune checkpoint blockade therapies and chimeric antigen receptor (CAR)-T cell therapies have demonstrated clinical efficacy against a variety of cancers. However, issues including limited patient responses, life-threatening off-target side effects, and poor efficacy against many solid tumors still limit the clinical utility of cancer immunotherapies. Biomaterial carriers of these therapies, though, enable one to troubleshoot the delivery issues, amplify immunomodulatory effects, integrate the synergistic effect of different molecules, and more importantly, home and manipulate immune cells in vivo. Through this “Biomaterials for Cancer Immunotherapy” symposium in 2025 SFB Annual Meeting, we aim to bring together scientists pursuing cutting edge research at the intersection of biomaterials and cancer immunotherapy. Topics of interest include but are not limited to: nanovaccine, nano-immunotherapy, biomaterial scaffold immunotherapy, adjuvanting materials, materials for immune cell engineering, immunological modeling systems, and lymphoid organoids.

Moderators:

Hua Wang, University of Illinois Urbana-Champaign
Brian Kwee, University of Delaware

Objectives

  • 8:00 AM. 318. Engineering A Biomaterials-based Lymphoid Niche for mRNA Lipid Nanoparticle Cancer Vaccines.Yining Zhu, M.S.E.1, Zhi-Cheng Yao1, Jingyao Ma1, Christine Wei1, Hai-Quan Mao1 1Johns Hopkins University

  • 8:15 AM. 319. Injectable adhesive hydrogel-based in situ vaccines eliminate established brain tumors by stimulating innate and adaptive immune responses that are enhanced by sustained release kinetics.Michelle Dion1, Alexander Cryer, PhD2, Daniel Dahis, PhD3, Pere Dosta, PhD4, Natalie Artzi, PhD5 1Harvard-MIT, 2Brigham and Women's Hospital, 3BWH, 4UTSW, 5Harvard Medical School

  • 8:30 AM. 320. Restoration of cGAS in tumor cells promotes antitumor immunity via transfer of tumor-cell generated cGAMP.Alexander Cryer, PhD1, Pere Dosta, PhD2, Michelle Dion3, Eliz Amar-Lewis, PhD1, Natalie Artzi, PhD4 1Brigham and Women's Hospital, 2University of Texas Southwestern, 3Harvard-MIT, 4Harvard Medical School

  • 8:45 AM. 321. Cancer vaccination using cell-mediated delivery of an adjuvant loaded via ionic liquid cocktail.Danika Rodrigues1, Kyung Soo Park2, Malini Mukherji1, Maithili Joshi1, Suyog Shaha1, Litsa Kapsalis3, Samir Mitragotri1 1Harvard University, 2Harvard Unversity, 3Harvard College

  • 9:00 AM. 322. Clickable Nanoplex Cluster-Mediated Synergistic Modulation of Dendritic Cells and T Cells Amplifies Tumor-Specific Adaptive Immunity.Wei Mao1, Hyuksang Yoo2 1Knagwon National University, 2Kangwon National University

  • 9:15 AM. 323. Plasmid DNA Vaccine for Post-Surgical Immunotherapy Against Murine Melanoma.Trishita Chowdhury1, Vanshika Singh1, Sudhakar Godeshala, PhD1, Jordan Yaron, PhD1, Kaushal Rege, PhD1 1Arizona State University

  • 9:30 AM. 324. Inhalable Unnatural Sugar for Tagging and Targeting of Lung Cancer Cells.Jiadiao (David) Zhou1, Hua Wang2 1University of Illinois Urbana Champaign, 2University of Illinois

  • 9:45 AM. 325. Macroporous Hydrogel-Based mRNA Cancer Vaccine for In Situ Recruitment and Modulation of Dendritic Cells.Ruike Dai1, Jiadiao (David) Zhou2, Hua Wang3 1University of Illinois at Urbana-Champaign, 2University of Illinois Urbana Champaign, 3University of Illinois

7C: Matrix & Peptides in Biomaterials

Date: Saturday, April 12, 2025
Time: 8:00 AM to 10:00 AM
Room: Joliet
Session Type: General Session

Description

Moderators:

Michael Floren, AlloSource
George Hussey
Chien-Chi Lin, Perdue University
Antonella Motta, University of Trento

Objectives

  • 8:00 AM. 342. Cartilage-Targeting and Drug Depot-Forming Cationic Fusion Protein of Insulin-Like Growth Factor 1 Analog.Bill Hakim1, Timothy Boyer1, Ambika Bajpayee, PhD1 1Northeastern University

  • 8:15 AM. 343. Development and In Vitro Evaluation of Biomimetic Injectable Hydrogels from Decellularized Human Nerves for Central Nervous System Regeneration.Gopal Agarwal, PhD1, Kennedy Moes1, Christine Schmidt1 1University of Florida

  • 8:30 AM. 344. HER2-targeting tandem peptide delivery of bioactive siRNAs targeting CD44 for treatment of HER2+ Breast Cancer.Audreanna Miserendino1, K. Lora Alatise1, Sevrina Tekle1, Anusha Vemula1, Brian Booth, PhD1, Angela Alexander-Bryant, PhD1 1Clemson University

  • 8:45 AM. 345. Engineered Decellularized Matrix Hydrogels to Mimic the Crypt-Villus Structures of the Small Intestine.Ngoc Ha Luong1, Van Thuy Duong1, Jonathan Barry Bryan1, Chien-Chi Lin, Ph.D.1 1Purdue University

  • 9:00 AM. 346. Application of Young and Aged Patterned Decellularized Muscle Bioinks.Krista Habing, B.S.1, Yong How Tan, B.S.1, Karina Nakayama, PhD1 1Oregon Health & Science University

  • 347. Characterization of POSH(3.3A)-Tat Peptide Amphiphile Micelles as Novel Therapeutic for Non-Hodgkin Lymphoma.Joshua Shelton, B.S.1, Aylin Kalabak1, Agustin Barcellona, B.S.1, Megan Schulte, Ph.D.1, Donald Burke, Ph.D.1, Mark Daniels, Ph.D.1, Bret Ulery, Ph.D.1 1University of Missouri - Columbia

  • 9:30 AM. 348. Developing and Characterizing an Engineered Collagen-Binding Fusion Protein to Enhance Localized Delivery of Bone Morphogenetic Protein-2 (BMP-2) for Bone Regeneration.Malvika Singhal, BS1, Marian Hettiaratchi, PhD1 1University of Oregon

  • 9:45 AM. 349. Decellularized Lymph Node Biomaterial Platform to Study the Impact of Microenvironment on Fibroblastic Reticular Cell Phenotype.Estefania Esparza, BS1, Alisa Fedotova2, Leonor Teles, BS1, Alice Tomei1, Mira Sayegh1 1University of Miami, 2Johns Hopkins University

7D: Engineering Cells and Their Microenvironments SIG 1

Date: Saturday, April 12, 2025
Time: 8:00 AM to 10:00 AM
Room: BLVD C
Session Type: General Session

Description

The Engineering Cells & Their Microenvironments Special Interest Group focuses on technologies and approaches at the single-cell level and the engineering of cellular microenvironments. This includes designing dynamic cues within biomaterials to regulate cell signaling and stem cell fate, as well as advancing stem cell manufacturing and differentiation, immunoengineering, and biomaterials for cell-based detection and diagnosis.

Moderators:

Janeta Zoldan, University of Texas
Kyle Lampe, University of Virginia
Silviya Zustiak, Saint Louis University

Objectives

  • 8:00 AM. 326. 3D Mechanical Confinement Directs Muscle Stem Cell Fate and Function.GaYoung Park1, Josh Grey2, Foteini Moukioti3, Woojin Han2 1Ichan School of Medicine at Mount Sinai, 2Icahn School of Medicine at Mount Sinai, 3University of Pennsylvania

  • 8:15 AM. 327. Characterization of Length-Scale Dependent Rheology using Bi-Disperse Multiple Particle Tracking Microrheology during Cell-Material Interactions.John McGlynn1, Kelly Schultz2 1Lehigh University, 2Purdue University

  • 8:30 AM. 328. Determining the Role of PIEZO1 in Stiffness Sensing and Regulation of Muscle Fibro-Adipogenic Progenitors.Kasoorelope Oguntuyo1, Britney Chin-Young1, Larion Martin Santiago1, Charlene Cai1, Woojin Han1 1Icahn School of Medicine at Mount Sinai

  • 8:45 AM. 329. Tissue-Penetrating Hyaluronic Acid Hydrogel Provides Multi-Modal Cartilage Microenvironmental Restoration.Tristan Pepper1, Lauren Foster2, Jay M Patel2, Thanh Doan2, Saitheja Pucha3 1Georgia Tech and Emory, 2Emory, 3Emory University

  • 9:00 AM. 330. Using a Library Approach to Identify Optimal Peptide Crosslinks for Cell-Responsive Hydrogels.Yingjie Wu1, E. Thomas Pashuck, PhD1 1Lehigh University

  • 9:15 AM. 331. Ultrafast-Relaxing and Photocrosslinkable PEG Hydrogels for Cell and Organoid Culture in 3D-Printable Dynamic Matrices.Bruce Kirkpatrick1, Lea Pearl Hibbard, BS2, Kristi Anseth1 1University of Colorado Boulder, 2University of Colorado

  • 9:30 AM. 332. Tunable and modular viscoelastic matrices to study morphogenesis and invasion of mammary epithelium.Jane Baude1, Ryan Stowers, Ph.D.1, Megan Li1, Abhishek Sharma1, Sabrina Jackson1, Daniella Walter1 1UC Santa Barbara

  • 9:45 AM. 333. Stimuli-Responsive Polyethylene Glycol Hydrogels with Dynamic Mechanical Properties.Michael Seitz1, Tessa Decicco2, Erik Schaeffer2, Era Jain, Ph.D.1 1Syracuse university, 2Syracuse

7E: Granular & Macroporous Biomaterials for Tissue Engineering 1

Date: Saturday, April 12, 2025
Time: 8:00 AM to 10:00 AM
Room: 4D
Session Type: General Session

Description

Granular hydrogel materials emerged as a class of biomaterial that provide for well-defined in vitro and in vivo systems with plug-and-play components and tissue-mimicking 3D environments. Granular hydrogels are composed of a slurry of microgel particles that are assembled to form a larger porous structure. Microporous annealed particle (MAP) scaffolds are a subclass of granular hydrogel material with a void space network stabilized by inter-particle chemical bonds. The modular nature of granular hydrogels offers enormous tunability in not only the individual microgel design but also the homogenous or heterogenous microgel assembly into the bulk scaffold. This session will explore current advances in granular hydrogel technology, including MAP scaffolds, for both immune modulation, tissue repair, organ-on-a-chip, and 3D-printing applications

Moderators:

Donald Griffin, University of Virginia
Tatiana Segura, Duke University

Objectives

  • 8:00 AM. 334. Stress Relaxation Rate of Alginate Microgel Scaffolds Affects Myogenic Differentiation.Andrea C Filler1, J. Kent Leach1 1UC Davis Health

  • 8:15 AM. 335. Enzyme Responsive Granular Hydrogels for Tissue Repair Post-Myocardial Infarction.Kendra Worthington1, Chima Maduka, DVM, PhD2, Amy Perry2, Jason Burdick3 1University of Colorado Boulder, 2BioFrontiers Institute, 3University of Colorado, Boulder

  • 8:30 AM. 336. Tuning the Morphological Properties of Granular Hydrogels to Control Lymphatic Capillary Formation.Daniel Montes Pinzon1, Sanjoy Saha1, Angela Taglione1, Donghyun Jeong1, Liao Chen1, Fei Fan1, Hsueh-Chia Chang1, Donny Hanjaya-Putra1 1University of Notre Dame

  • 8:45 AM. 337. Toward a Multicellular, Gelatin-based Granular Hydrogel Model of the Bone Marrow.Brendan Harley, ScD1, Gunnar Thompson, B.S.1 1University of Illinois Urbana-Champaign

  • 9:00 AM. 338. Bioprinting and Microvascular Assembly within PEGNB Granular Materials.Irene Zhang1, Lucia Choi1, Andrew Putnam, Ph.D.1 1University of Michigan

  • 9:15 AM. 339. Dynamic granular hydrogels as an in vitro cancer model.Ellen Frahm1, chun-Yi Chang1, Chien-Chi Lin, Ph.D.1 1Purdue University

  • 9:30 AM. 340. Tuning Mesenchymal Stem Cell Extracellular Vesicle Content Through Extracellular Cues in Microgel Scaffolds.Matthew Jaeschke1, Georgios Tseropoulos1, Nicole Friend1, Mark Young1, Abigail Bole1, Kristi Anseth2 1University of Colorado, Boulder, 2University of Colorado Boulder

  • 9:45 AM. 341. TissueFab® Porous Bioink for the Next Generation of 3D Bioprinting.Vinson Chu1, Elizabeth Aisenbrey1 1MilliporeSigma

7F: Nanomedicine for Targeted Drug Delivery - 2

Date: Saturday, April 12, 2025
Time: 8:00 AM to 10:00 AM
Room: BLVD A
Session Type: General Session

Description

This session will emphasize product development and translational nanomedicine, including but not limited to evaluation of product effectiveness in vivo in disease models, nanomedicine manufacturing, and nanomedicine quality control for specific applications. Nanomedicines include colloids and other nanomaterials that have been engineered to target delivery of diverse payloads (such as small molecules, nucleic acids, or biologics) to specific cells or tissues. Targeting approaches may include but are not restricted to cell membrane coating, surface modification, engineering of particle geometry, or engineering other biophysical parameters. Abstracts from academic researchers with translational products or devices are welcomed and abstracts from industry members are especially encouraged.

Moderators:

John Clegg, The University of Oklahoma
Kelly Langert, Loyola University Chicago

Objectives

  • 8:00 AM. 350. Development of Nanomedicines for Targeting and Preventing Pancreatic β-Cell Death.Jubril Akolade, Ph.D.1, Jillian Collins, Ph.D.1, Isaac Crossley1, Ashton Fremin, Ph.D.1, Nikki Farnsworth, PhD1 1Colorado School of Mines

  • 8:15 AM. 351. Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain.Emily Han, BS1, Michael Mitchell, Ph.D.1 1University of Pennsylvania

  • 8:30 AM. 352. Optimizing nanoparticle geometry to enhance drug delivery to the brain by the intrathecal route.Kha Uyen Dam, BS1, Elena Andreyko, PhD1, Chung-Fan Kuo, PhD1, Oluwatobi Babayemi, BS2, Rachael Sirianni, PhD1 1UMass Chan Medical School, 2Rice University

  • 8:45 AM. 353. Harnessing Dendrimers for Targeted Drug Delivery to Neurons.Anjali Sharma, PhD1, Anubhav Dhull, MS1, Zhi Zhang, PhD2, Rishi Sharma, PhD1, Aqib Iqbal Dar, PhD1 1Washington State University, 2University of Michigan -Dearborn

  • 9:00 AM. 354. Platelet-inspired Intravenous Nanomedicine enabling Injury-Targeted Thrombin Delivery for Hemorrhage Control.Abigail Roeckmann1, Bipin Chakravarthy Paruchuri2, Rohini Sekar2, Danielle Sun2, Dante Disharoon2, Anirban Sen Gupta2 1Case Western Reserve University, 2Case Western Reserve Society

  • 9:15 AM. 355. mRNA-LNP Delivery to the Damaged Spinal Cord.Jacobus Burger1, Daniel Hellenbrand, PhD2, Luke Bolstad3, Amgad Hanna, MD4, William Murphy, PhD5 1University of Wisconsin-Madison, 2University of Wisconsin- Madison, 3University of Wisconsin, 4University of Wisconsin - Madison, 5University of Wisconsin Madison

  • 9:30 AM. 356. Formulation methods for peptide-modified lipid nanoparticles.Katelyn Miyasaki1, Sangwoo Han, Ph.D. Chemical Engineering - University of Seoul, 20221, Ester Kwon, Ph.D. Bioengineering -- University of Washington2, Olivia Carton2, Rebecca Kandell, Ph.D. Bioengineering -- UC San Diego, 20232, Jonathan Gunn2 1University of California San Diego, 2UC San Diego

  • 9:45 AM. 357. Precision-Targeted Stem Cell-Derived Extracellular Nanovesicles for Elastic Matrix Regenerative Repair in Abdominal Aortic Aneurysms (AAAs).Anand Ramamurthi, PhD, FAHA1, Ali Abba Mutah, DVM, MVSc2 1Lehigh University, 2Lehigh University, Bethlehem PA.

7G: Novel Materials - Biologically Inspired

Date: Saturday, April 12, 2025
Time: 8:00 AM to 10:00 AM
Room: 4C
Session Type: General Session

Description

Bioinspiration from nature can be drawn through structural, functional, or organizational properties. With their tunable properties, bioinspired materials can mimic different aspects of natural structures and have shown promise in various clinical applications. For example, they have been used as biomimetic scaffolds in tissue engineering and regenerative medicine to promote tissue healing and integration. In drug delivery, bioinspired materials can be designed for targeted and controlled release, improving efficacy, reducing side effects, and ensuring a consistent therapeutic effect. Additionally, bioinspired materials are utilized in implants and medical devices due to their integration with the body, which reduces the risk of rejection and improves longevity.

While bioinspired materials are cytocompatible, effective, and sustainable compared to traditional materials for clinical applications, there are challenges in clinical translation including regulatory aspects.

Moderators:

Gulden CamciUnal, Univeristy of Massachusetts Lowell
Nasim Annabi, UCLA

Objectives

  • 8:30 AM. 360. Bioinspired and Mechanically Robust Nanostructured Block Copolymer Hydrogels.Arkodip Mandal1, Matthew Davidson2, Abhishek Dhand3, Michael Toney1, Jason Burdick2 1University of Colorado Boulder, 2University of Colorado, Boulder, 3University of Pennsylvania8

  • 8:45 AM. 361. Chemically Modified Rhamnan Sulfate Compounds as Therapeutics for Metabolic Dysfunction-Associated Steatotic Liver Disease.Gregory Callahan1, Amol Vibhute, PhD1, Cassandra Callmann, PhD1, Aaron Baker, PhD1 1University of Texas at Austin

  • 9:00 AM. 362. Liquid-liquid Phase Separating Peptide Condensates for Therapeutic Delivery.Ushasi Pramanik1, Anirban Das1, Elise Brown1, Heather Struckman1, Huihao Wang1, Sam Stealey, PhD2, Macy Sprunger1, Abdul Wasim3, Jonathan Fascetti1, Jagannath Mondal3, Jonathan Silva1, Silviya Zustiak, PhD2, Meredith Jackrel1, Jai Rudra, PhD4 1Washington University in St. Louis, 2Saint Louis University, 3TIFR Hyderabad, 4Washington University in Saint Louis

  • 9:15 AM. 363. Regulating Diabetic Fibroblasts Using Bioinspired Hyaluronan Binding Silk Hydrogels.Amelia Huffer1, Noah Terkildsen2, Lichong Xu3, Roman Shchepin2, Tugba Ozdemir2 1South Dakota School of Mines andTechnology, 2South Dakota School of Mines and Technology, 3Penn State College of Medicine

  • 9:30 AM. 364. Unconventional Biomaterials for Tissue Engineering and Regenerative Medicine.Gulden Camci-Unal, PhD1 1University of Massachusetts Lowell

  • 9:45 AM. 365. Making Synthetic Hydrogels Inspired by Spider Silk.Ruth Ebubechukwu, BS1, E. Thomas Pashuck, PhD2 1Lehigh Universities, 2Lehigh University

Speakers

7H: Orthopaedic Biomaterials SIG 3

Date: Saturday, April 12, 2025
Time: 8:00 AM to 10:00 AM
Room: 4A
Session Type: General Session

Description

There are increasing demands for orthopedic biomaterials which play critical roles in patient care. This session invites presentations on metals, ceramics, and polymers that are used every day in modern orthopedic applications. Particular focuses will include octacalcium phosphates, bioabsorbable metallic materials, biomaterial degradation and impacts, and additive manufacturing. Applications will span across orthopedic, cardiovascular, craniomaxillofacial implants, etc. In vitro, in vivo, and in silico studies, as well as studies focusing on commercialization and clinical/translational challenges are welcome.

Objectives

  • 8:00 AM. 366. Independent Control of Biochemical and Physical Cues in 3D-Printed Scaffolds.Andrew Kitson1, Santiago Lazarte2, Brandon Krick, PhD3, Lesley Chow, PhD1 1Lehigh University, 2Florida State University, 3Florida A&M University-Florida State University

  • 8:15 AM. 367. Fabrication of Bisphosphonates Nanoparticles in Microparticles as Macrophage Targeting and Inflammation Modulating Drug Delivery System for Osteoarthritis Therapy.Paul Sagoe1, Era Jain, Ph.D.1 1Syracuse University

  • 8:30 AM. 368. Resurfacing-Regenerative Approach to Repair Osteochondral Defects using a Bioprosthetic Device.Olivia Dingus, B.S.1, Courteney Roberts, B.S.1, Connor Demott, Ph.D.1, Lauren Davis, Ph.D.1, W. Brian Saunders, Ph.D., D.V.M.1, Melissa Grunlan, Ph.D.1 1Texas A&M University

  • 8:45 AM. 369. An Engineered Hydroxyapatite-Binding Fusion Protein to Improve Localized Delivery of Bone Morphogenetic Protein-2 (BMP-2) for Bone Regeneration.Malvika Singhal, BS1, Caroline Foskett1, Marian Hettiaratchi, PhD1 1University of Oregon

  • 9:00 AM. 370. Application of flow synthesis method for stable synthesis of OCP.Keizo Hosoya1, Tomohiro Hayashi1, Yuka Maruko1, Ryo Hamai2, Osamu Suzuki2 1Japan Fine Ceramics Co., Ltd., 2Tohoku University Graduate School of Dentistry

  • 9:15 AM. 371. Biohybrid Shape Memory Polymer (SMP) Scaffolds for Potential Bone Regeneration and Infection Resistance.Damion Dixon, Ph.D.1, Ainsley Shields2, Melissa Grunlan, Ph.D.1 1Texas A&M University, 2Texas A&M Univeristy

  • 9:30 AM. 372. Impact of Process Parameters and Heat Treatment on Pitting Corrosion in Additively Manufactured CoCrMo Implant Alloy.Amandine Impergre, PhD1, Nick Hantke, PhD2, Julia Hochstatter3, Alfons Fischer, Prof4, Jan Sehrt, Prof2, Robin Pourzal, PhD3 1Clemson University, 2Ruhr-University Bochum, 3Rush University Medical Center, 4Max-Planck-Institut

  • 9:45 AM. 373. Potential toxicity from Implant Wear Products – Cobalt, Chromium, and Titanium Ions on Neuroblastoma IMR-32.Vanaja Narayanaswamy, B-Tech1, Mareeswari Paramasivan, PhD1, Mathew Mathew, PhD1, Xuejun Li, PhD1 1University of Illinois Chicago